Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Frontiers in Immunology|September 12, 2024
Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicityMichel Siegel, Anna-Lena Bolender, Axel Ducret, et al.
Plos One|April 25, 2013
Crystal structure of an anti-Ang2 CrossFab demonstrates complete structural and functional integrity of the variable domainSebastian Fenn, Christian B Schiller, Julia J Griese, et al.
Plos One|June 25, 2014
Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regionsJasmin F Sydow, Florian Lipsmeier, Vincent Larraillet, et al.
Frontiers in Molecular Biosciences|March 4, 2022
Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody FormatsMonica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodiesWolfgang Schaefer, Jörg T Regula, Monika Bähner, et al.
Frontiers in Molecular Biosciences|February 14, 2022
Comparing Antibody Interfaces to Inform Rational Design of New Antibody FormatsMonica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Mabs|March 18, 2016
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancerJuergen M Schanzer, Katharina Wartha, Ekkehard Moessner, et al.
Mabs|February 23, 2023
Assessing developability early in the discovery process for novel biologicsMonica L Fernández-Quintero, Anne Ljungars, Franz Waibl, et al.
Mabs|September 19, 2019
DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicityClaudio Sustmann, Steffen Dickopf, Jörg T Regula, et al.
Pageof 4